(Q46435466)

22 December 2017

title

Dopamine transporter genotype and methylphenidate dose response in children with ADHD. (English)

1 reference

22 December 2017

0 references

8

Edwin H Cook

1 reference

22 December 2017

Mark A Stein

1

1 reference

22 December 2017

Irwin D Waldman

2

1 reference

22 December 2017

Christopher S Sarampote

3

1 reference

22 December 2017

Karen E Seymour

4

1 reference

22 December 2017

Adelaide S Robb

5

1 reference

22 December 2017

Charles Conlon

6

1 reference

22 December 2017

Soo-Jeong Kim

7

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

22 December 2017

published in

Neuropsychopharmacology

1 reference

22 December 2017

volume

30

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

1374-1382

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300718

exact match

0 references

cites work

Basal ganglia volumes in children with attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Toward a pathophysiology of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Quantitative Brain Magnetic Resonance Imaging in Attention-Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Stimulant treatment over five years: adherence, effectiveness, and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Treatment of attention-deficit-hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Genotype influences in vivo dopamine transporter availability in human striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Functional effects of the DAT1 polymorphism on EEG measures in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Dopamine transporter gene associated with diminished subjective response to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Psychiatric pharmacogenetics: personalizing psychostimulant therapy in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Adaptive skills dysfunction in ADD and ADHD children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Genetics of attention deficit/hyperactivity disorder: are we ready for molecular genetic studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

No association of the dopamine transporter gene 3' VNTR polymorphism with ADHD subtypes in a population sample of twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Association of the dopamine transporter gene (DAT1) with poor methylphenidate response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Attention-deficit disorder. Born to be hyperactive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Brain metabolism in teenagers with attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

7 January 2021

Forty years of methylphenidate treatment in Attention-Deficit/ Hyperactivity Disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

7 January 2021

Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

7 January 2021

DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

7 January 2021

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

7 January 2021

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

7 January 2021

Mechanism of action of methylphenidate: insights from PET imaging studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300718

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300718

1 reference

22 December 2017

1 reference

22 December 2017